Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

PharmaCyte Biotech (pmcb)

Total paid for Promotions this month: $0
E-mails this Month: 1
Estimated Volume Generated: $0
Research Report on pmcb: Click to see
* The information presented is based on information for Jun , 2016
  Our New Pick Is PMCB Good Morning Traders!Without Further Ado: Today’s monster market freak is PMCB.Here’s the deal: We are knocking on the door of 400% in gains on the year, and solidly on pace for our second consecutive month of 250%-plus in gains to start 2015. And today’s alert in PMCB is only going to add to that picture.This stock is starting to rally after a major check ...read more
Promoter: Value Penny Stocks Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $6,000 UNKNOWN
Max Profit: 8.52 % Gain at close: Pending
Good Morning,   New Trade Alert: PharmaCyte Biotech, Inc. [ PMCB ] ‚Äč PMCB is my latest monster pick for a few main reasons: PMCB is rebounding from recent historical lows - providing us with massive upside at a discounted price - only 13 cents a share. In 2015 traded as high as 21 cents. Biotech has been one of the strongest performing sectors - PMCB is one of the few that is still potentially undervalued! PMCB ...read more
Promoter: HiddenGemStocks.com Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $15,000 UNKNOWN
Max Profit: 8.52 % Gain at close: Pending
Hi there,   You Don't Have to Risk a Dime! Just Follow Us And See For Yourself.  According to Bloomberg, 1,003 stocks are up 100% or more this past year. 189 stocks are up at least 10 to 1. And that's in the U.S. alone.  Include foreign markets and you're looking at 389 10-baggers in the past 12 months. So it can and does happen—a lot.  No matter how volatile a market is... no matter if it goes up or down... We ...read more
Promoter: Brilliant PS Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB Unknown compensation UNKNOWN
Max Profit: 8.52 % Gain at close: Pending
   February 6, 2015 Volume XVIII, Issue 4   OTC Journal Newsletter   PharmaCyte's (PMCB)Diabetes Treatment: How Would It Work? How much would a cure for diabetes be worth? It's incalculable, but certainly many billions of dollars. Consider the insulin market alone is over $25 billion annually and projected to reach $40 Billion by 2018. Diabetes is a worldwide epidemic. ...read more
Promoter: OTCJournal Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $5,000 UNKNOWN
Max Profit: 1.05 % Gain at close: Pending
    PharmaCyte Biotech Inc (PMCB)     Traders,   Today hasn't gone exactly to plan but I am confident in my analysis.   This small pullback could be an excellent opportunity so make sure you keep your eyes peeled on PMCB into the power hour as we could have a nice close.   If you haven't read my analysis on PMCB below, please do so now.   Let's bank into the close.   FMA   -------------------------------------------------------------------- ...read more
Promoter: Penny Stock General Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $2,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
    PharmaCyte Biotech Inc (PMCB)     Traders,   Our biotech play deliver solid 18% gains today and close near highs, tomorrow we focus on another biotech play making big waves.   Check out PharmaCyte Biotech Inc (PMCB) now.   Yesterday, PCMB announced major news that it had initiated it first pre-clinical study of its Encapsulated Cell Product for Novel Treatment of Diabetes, check it out at http://finance.yahoo.com/news/pharmacyte-biotech-initiates-first-preclinical-140000968.html ...read more
Promoter: Stock Shock and Awe Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $2,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
    PharmaCyte Biotech Inc (PMCB)     Traders,   Our biotech play deliver solid 18% gains today and close near highs, tomorrow we focus on another biotech play making big waves.   Check out PharmaCyte Biotech Inc (PMCB) now.   PMCB is a highly liquid trader that has pulled back significantly over the past few months.    Today however, PMCB saw a strong uptick as it found support at $0.10 last ...read more
Promoter: Stock Shock and Awe Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $2,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
  PharmaCyte Biotech Inc (PMCB)     Traders,   Our biotech play deliver solid 18% gains today and close near highs, tomorrow we focus on another biotech play making big waves.   Check out PharmaCyte Biotech Inc (PMCB) now.   PMCB is a highly liquid trader that has pulled back significantly over the past few months.    Today however, PMCB saw a strong uptick as it found support at $0.10 last week.   We ...read more
Promoter: Penny Stock General Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $2,000 UNKNOWN
Max Profit: 0.00 % Gain at close: Pending

Meet PMCB And Its NEWS Feb 03, 2015 09:41

  Pre-Clinical Stage Biotech For Barely $0.10     Greetings, Trader!   PharmaCyte Biotech Inc. (PMCB) may be a new ticker for you but the company is finally hinting that it’s tired of its technology getting ignored.   PMCB HAS WHAT MIGHT BE A CURE FOR DIABETES ON ITS BOOKS! AND AS OF YESTERDAY, IT’S MOVING TOWARD THE CLINIC! (Read more)   That ...read more
Promoter: Stock Preacher Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $14,500 UNKNOWN
Max Profit: 13.08 % Gain at close: Pending
  Pre-Clinical Stage Biotech For Barely $0.10   Greetings, Trader!   PharmaCyte Biotech Inc. (PMCB) may be a new ticker for you but the company is finally hinting that it’s tired of its technology getting ignored.   PMCB HAS WHAT MIGHT BE A CURE FOR DIABETES ON ITS BOOKS! AND AS OF YESTERDAY, IT’S MOVING TOWARD THE CLINIC! (Read more)   That ...read more
Promoter: Micro Stock Profit Paying Party: Cream Consulting
Stocks covered: Compensation: Avg $ Volume for Period:
PMCB $14,500 UNKNOWN
Max Profit: 13.08 % Gain at close: Pending
First  << 11  12  13  14  15  16  17  18  >> Last